乳房切除指征与组织扩张器乳房再造并发症的关系
研究纳入2011至2017年在耶鲁纽黑文医院接受两阶段植入物乳房再造的141例患者共226侧乳房切除,比较治疗性与预防性乳房切除的围手术期并发症。回归分析显示治疗性乳房切除的皮瓣坏死风险显著更高,校正混杂因素后风险为预防性组的9.5倍,其他再造并发症无显著差异。
要点
- 治疗性乳房切除较预防性乳房切除的皮瓣坏死风险显著升高(p=0.017)。
- 校正混杂因素后,治疗性乳房切除皮瓣坏死风险为预防性组的9.5倍。
- 两组在其他再造并发症上无显著差异。
核心结论
- 治疗性乳房切除患者发生乳房切除皮瓣坏死的风险显著高于预防性乳房切除患者。
- 具体原因尚待确定,但技术差异可能与皮瓣坏死相关。
研究设计与样本
- 回顾性研究,纳入2011至2017年耶鲁纽黑文医院接受两阶段组织扩张器/永久植入物乳房再造的患者。
- 共141例患者、226侧乳房切除,其中治疗性134侧、预防性92侧。
- 采用卡方分析、t检验和Fisher精确检验比较并发症,二元逻辑回归分析皮瓣坏死的相关变量。
主要发现
- 回归分析显示两组在人口学、合并症及切除与再造细节上无显著差异,仅治疗性组改良根治性乳房切除更多(p=0.003)。
- 治疗性组乳房切除皮瓣坏死风险显著更高(p=0.017)。
- 校正混杂变量后,治疗性乳房切除的皮瓣坏死风险为预防性乳房切除的9.5倍。
- 两组其他再造并发症无显著差异。
临床怎么用
- 对治疗性乳房切除患者应更警惕皮瓣坏死风险,加强术后皮瓣监测。
- 术前咨询时可依据指征向患者说明皮瓣坏死的相对风险差异。
局限性
- 单中心回顾性研究,样本来自单一机构。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Two-stage implant breast reconstruction is the most commonly performed breast reconstruction procedure. Limited data exist regarding reconstruction complication rates examined by mastectomy indication. METHODS: Patients who underwent two-stage implant breast reconstruction at Yale New Haven Hospital from 2011 to 2017 were included in the study. Perioperative complications were compared. Chi-square analysis, t tests, and Fisher's exact tests were used to determine significant associations. A binary logistic regression was used to determine variables with a significant impact on the likelihood of mastectomy flap necrosis. RESULTS: Between 2011 and 2017, complete perioperative records were available for 141 patients who underwent 226 mastectomies followed by two-stage tissue expander/permanent implant reconstruction. Of the 226 mastectomies, 134 were therapeutic and 92 were prophylactic. On regression analysis, there were no significant differences in demographics, comorbidities, or mastectomy and reconstructive details between the two breast groups except for there being more modified radical mastectomies in therapeutic breasts (p = 0.003). When comparing complications, there was a significantly higher risk of mastectomy flap necrosis in the therapeutic group (p = 0.017). Therapeutic mastectomies had a 9.5 times higher risk of mastectomy flap necrosis than prophylactic mastectomies when adjusted for confounding variables. There were no significant differences in other reconstructive complications between the two groups. CONCLUSIONS: Patients undergoing therapeutic mastectomies have a significantly higher risk of mastectomy flap necrosis than those undergoing prophylactic mastectomies. Although the underlying cause still needs to be determined, differences in technique may be related to mastectomy flap necrosis. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, II.
引用
- Chouairi F, Gabrick KS, Avraham T, et al. Complication Profiles by Mastectomy Indication in Tissue Expander Breast Reconstruction. Plast Reconstr Surg. 2019. PMID: 30730496. doi:10.1097/PRS.0000000000005423
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。